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Abstract 
“Fluorescence imaging” is a particularly exciting and rapidly developing area of research, the annual number of 
publications in the area has increased ten-fold over the last decade. The rapid increase of interest in fluorescence 
imaging will necessitate the development of an increasing number of molecular receptors and binding agents in order 
to meet demand in this rapidly expanding area. Carbohydrate biomarkers are a particularly important target for 
fluorescence imaging given their pivotal role in numerous important biological events, including the development 
and progression of many diseases. Therefore, the development of new fluorescent receptors and binding agents for 
carbohydrates are and will be in increasing demand. This review highlights the development of fluorescence imaging 
agents based on boronic acids being a particularly promising class of receptor given their strong and selective binding 
with carbohydrates in aqueous media.  
Introduction 
Molecular imaging, is a very important tool in life sciences and engineering, and has been a particularly fast growing 
area of research over the past decade. Imaging techniques have been using as powerful tools to help understanding 
the function and structural characteristics of tissue using intrinsic absorption and scattering via in vivo and in vitro 
spectroscopic and microscopy techniques.1, 2 In particular, much attention has been paid to fluorescence 
investigations of cells and tissues since many biochemical markers can be visualised using fluorescence contrast 
agents, and they can also be targeted using appropriate fluorescent markers.3-5 Therefore, imaging techniques are 
important for developing and testing novel tools, reagents, and methods to visualise specific molecular processes in 
vivo, particularly those that are key targets in disease processes.6 
Various imaging modalities, such as positron emission tomography (PET), single photon emission computed 
tomography (SPECT), optical fluorescence imaging, magnetic resonance imaging (MRI), computed tomography 
and ultrasound imaging, and recently total internal reflection fluorescence microscopy (TIRFM), have been 
successfully employed in biomedical imaging.7 Using these techniques for imaging, in conjunction with fluorescence, 
allows cellular events to be tracked providing biological information at the molecular level in living systems.8 To 
meet the requirement for in vivo clinical molecular imaging, the design of highly sensitive and specific molecularly 
targeted imaging probes is required.8, 9 Imaging probes are often synthesised by combining various functional 
moieties (i.e. radioisotopes, fluorophores, and nanoparticles) with receptors (i.e. boronic acids, macrocyclic crown 
ethers).10, 11 Given the successful development of single-molecule super-resolution fluorescence imaging, precise 
and accurate bio-tagging and labelling can be investigated, thus potential preclinical and biomedical detection of 
certain diseases at an early stage may be possible in the near future.12, 13 Fluorescence molecular imaging will allow 
us to answer basic in vivo biological questions and more importantly it could be achieved in a high-throughput 
fashion.14 This review aims to capture the state-of-the-art in the emerging field of saccharide-led imaging; although 
still in its infancy, the authors of this report believe there is an unrealised potential for saccharide based imaging to 
transform the area and offer new paradigms in biomedical research.  
Saccharides and Carbohydrates 
Carbohydrates are vital to biological processes, and as such are important in disease diagnosis.15 For 
example unregulated glucose levels in the blood and associated with diabetes, which can lead to deleterious 
healthcare implications such as kidney problems, heart disease, nerve damage (leading to amputations) and 
even blindness.16-19 Excess blood glucose forms non-enzymatically generated conjugates and these glycated 
products are what led to the damage associated with diabetes. Indeed, glycated hemoglobin (HbA1c) can be 
monitored to give an indication of plasma glucose.20 Such problematic glycation is more often witnessed in 
proteins with a long lifetimes.21,22 Human serum albumin (HSA), the most prevalent blood protein, has a 
faster turnover rate than hemoglobin thus comparisons between levels of HAS and hemoglobin glycation 
can offer meaningful insight into time-dependant variations of blood sugar chemistry.  
Glycated proteins offer the potential as disease markers and they are potential probes for diseases including 
certain types of cancer, Alzheimer’s disease (AD), autoimmune diseases and atherosclerosis. Some of the 
symptoms of AD, including plaques and cell death have been linked with insulin mechanisms, because of 
this link in some reports the disease has been called type 3 diabetes.23 Whilst further research remains to be 
carried out to back-up these hypotheses, the detection of glycated proteins has the potential to offer new 
diagnostic regimes for clinicians in the future. It is already known that excess Advanced Glycation End 
products (AGE) arising from hyperglycemia are important indicators for complications related to diabetes.24, 
25 
 
 
 
 
 
Table 1. Structure information on the protein26 
Protein Major associated carbohydrates 
Lectin Terminal α-1,3 mannose 
α-galactose, GlcNAc, α-2,3 sialic acid, β-fucose,   
Ovalbumin (Oval) Mannose, N-acetyl glucosamine, galactose 
Bovine submaxillary mucin (BSM) 
Porcine stomach (PSM) 
Sialic acid, N-acetyl glucosamine, N-acetyl galactose, 
fucose, galactose 
Carcinoembryonic antigen (CEA) Sialic acid, N-acetyl glucosamine, N-acetyl galactose, 
fucose, galactose, LeX, Lea, and Leb antigen 
 
Cell surface carbohydrates, as part of glycosylated proteins and lipids, have been associated with different 
types of cells and these surface carbohydrates present the characteristic signature of cancers’ development 
and progression, such as sialyl Lewis X (sLex), sialyl Lewis A (sLea), Lewis X (Lex) and Lewis Y (Ley) 
(Figure 1).27 Poly- and oligosaccharides localised on the microbial cell walls and animal cells surfaces can 
be targeted using sugar-specific ligands. Using these sugar-specific antibodies and lectins for controllable 
attachment and detachment of cells, fluorescence molecular imaging can be used for the diagnostic tracking 
of certain diseases or tumors.  
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Figure 1: Structures of cell-surface carbohydrates, biomarkers sialyl Lewis X (sLex), sialyl lewis A (sLea), Lewis X (Lex), 
Lewis Y (Ley). The hydroxyl groups which are most likely to bind with boronic acid groups are highlighted in red.  Boronic 
acid receptors bind reversibly to cis-1,2- and –1,3-diols, a detailed study to ascertain which diols do bind remains to be 
completed. 
Fluorescence for imaging applications 
Since the first description of phenomenon of fluorescence by Sir George Gabriel Stokes in 1852,28 the 
fluorescence-related techniques have been considered as powerful tools by chemists and biologists. 
Fluorescence in conjunction with microscopy can be used for the detection and visualization of biological 
and physiological processes and lead to a deeper understanding of diseased-specific mechanisms.4, 10 
Fluorescent probes/molecules are widely recognized as powerful sensing and imaging tools,2, 8, 11 which 
have been successfully developed for a large number of biomolecules, including glutamate,29 
acetalcholine,30 glycine,31 aspartate32 and dopamine.33 Fluorescence is particularly useful to directly 
interrogate cell chemistry and understand the function.34-36 The multitude of positive features, such as high 
sensitivity, in real-time, easy manipulation, coupled with widely available instrumentation, make 
fluorescence one of the most powerful transduction mechanisms to report on chemical-biological 
recognition events.  
Fluorescent dyes can be applied to enhance image contrast in confocal fluorescence microscopy.37 The design of 
fluorescence probes with the ability to signal, sense and target carbohydrate substrates in living systems requires the 
optimisation of a number of factors, including chemoselectivity and bioorthogonality.38 In the search for synthetic 
receptors a bottom-up design is often required, despite the apparent challenge of designing new receptors for each 
analyte, there are a number of recognition motifs that offer many advantages in receptor design, such as boronic 
acids and their ability to sequester saccharides under biologically relevant conditions.6, 39 
Light in the Near-infrared (NIR) and Far-red region can propagate through several centimeters of tissue, 
therefore, in a practical sense the use of a NIR fluorescent signals to detect tumors and other diseases in situ 
and at very early stages of development is desirable.8 It should then be possible to use imaging techniques 
to speed up drug screening, and to use imaging as an objective endpoint for tailoring therapies towards an 
individual patient.40, 41 Therefore, the development of “smart”42 and targeted fluorescent molecular probes 
with NIR emission is a particularly important area of interest. 
Boronic acid for imaging carbohydrates 
Boronic acids have been exploited extensively as chemo/biosensors in the detection of saccharides, anion, 
and reactive oxygen and nitrogen species (ROS/RNS) through electrochemical, fluorescent, and 
colorimetric measurements.6, 43-47 Notably, over the physiological pH range, boronic acids are an ideal 
molecular receptor for 1,2- or 1,3-diols (e.g. monosaccharides) since boronic acid derivatives rapidly and 
reversibly interact with saccharides in aqueous media, and thus importantly the method does not consume 
the analyte.48-50 Boronic acid-based molecules and boronate-modified materials have shown great utility in 
sensing and imaging saccharides and complex glycoproteins.51, 52 In terms of common cell attachment and 
detachment protocols, boronic acid derivatives can be utilised to bind with native poly- and oligosaccharides 
which are present in the outer cellular wall or membrane.53 By combining boronic acid with fluorescence 
dyes or Quantum Dots (QDs) or other signal reporter units, researchers have developed sensing and labeling 
systems for the recognition of carbohydrate biomarkers.44 Since, the fluorescence quenching of probes is 
often hard to avoid, the development of effective boronic acid-based carbohydrate fluorescent sensors could 
be hampered. However, seminal research by Tang and co-workers has shown that aggregation-induced 
emission (AIE) systems based on tetraphenylethene (TPE) could be used  to avoid quenching problems in 
the development of saccharide selective probes.54 In this feature article, we have classified boronic acid-
based fluorescent probes for carbohydrate imaging into several categories: small-molecular probes, 
polymer-tagged probes and benzoxaborole-based probes. 
Small-molecule probes for imaging applications 
Over the past decade two types of small-molecule boronate-based sensors in the imaging of carbohydrates 
have been used: mono-boronic acid probes and bisboronic acid probes. Noticeably, bisboronic acids are 
more widely used due to the increased number of binding sites for interaction with carbohydrate bio-
markers.6, 55 The increased number of binding sites between the boronic acid receptor and carbohydrates 
results in a strong binding affinity and hence improved labeling or imaging of the target carbohydrate.49, 50, 
56 For example, in 2002, Wang and co-workers57 designed and synthesised a series of fluorescent bisboronic 
acid probes by changing the linker between the bisboronic acid units, producing receptors for the detection 
of sialyl Lewis X (sLex). Among them, compound 1 with the strongest affinity for sLex displayed specific 
labeling of sLex-expressing HEPG2 cells, whilst non-sLex-expressing cells were not labeled in the control 
experiment (Figure 2).   
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Figure 2. Structure of compound 1 and fluorescent labeling studies of sLex-expressing HEPG2 cells (bottom) and non-expressing 
COS7 cells (top) with compound 1 (5 μM). Reproduced with permission from (Bioorg. Med. Chem. Lett., 2002, 12, 2175). Copyright 
© 2002 Elsevier Ltd. 
Wang and co-workers58 have also evaluated compound 1 and compound 2 for the selective labeling of cell-
surface sLex (HEPG2 cells) over Lewis Y (HEP3B cells). With detection levels for sLex of 0.5 to 10 µM 
using compound 1 (5 µM), and resulting in the specific imaging of HEPG2-expressed sLex over HEP3B-
expressed Lewis Y (Figure 3). However, the specific binding mode between probe 1 and sLex which 
produces this selectivity was not well understood.     
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Figure 3. Structure of compound 2 and fluorescent Labeling Studies of HEPG2, HEP3B, and COS7 Cells by using compound 1 
and 2. HEPG2 cells express only sLex, HEP3B cells express only Lewis Y, and COS7 cells do not express either antigen. Reproduced 
with permission from (Chem. Biol., 2004, 11, 439). Copyright © 2004 Elsevier Ltd. 
Based on Wang’s work, a similar bisboronic acid receptor was developed by Craig.59 Three bisanthracene bisboronic 
acid derivatives were investigated (compounds 1, 3 and 4), with binding affinities towards D-fructose of 212 M-1, 
266M-1 and 504 M-1 respectively and binding constants towards D-glucose of 28 M-1, 1 M-1 and 2 M-1 respectively. 
The compounds were used for labeling liver carcinoma cells HEPG2 and a normal fibroblast mammalian cells COS-
7, the non-labeled cells presented as grey images and labeled cells can be seen with a blue color in their images. The 
staining results shown in Figure 4 indicate that both compound 1 and 3 stain the HEPG2 cells and compound 1 
stained COS-7 cells while compound 4 showed weak or no binding affinity for either cell line. The non-selective 
labeling when using compound 1 is in contrast to the earlier work which indicated specificity toward hepato-cellular 
carcinoma cells versus normal fibroblast cells. 
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Figure 4. Structures of compound 3 and 4. Fluorescent labeling studies of a liver carcinoma cell line HEPG2 and a normal 
fibroblast mammalian cell line COS-7 with compounds 1, 3 and 4. The negative control contains buffer only. Reproduced with 
permission from (Bioorg. Chem., 2012, 40, 137). Copyright © 2012 Elsevier Ltd.  
In extending this work, Wang and co-workers60 have linked the carbohydrate biomarker-targeting small molecule 1 
and matrix-free MALDI mass spectrometric tag using click chemistry to produce the boronolectin-trityl reporter 5. 
The new system was used to track cancer cell surface sLex expression in freshly-frozen renal tissues. Figure 5a shows 
that the system can specifically bind only in the region of the tumor with sLex expression, and also in alcohol fixed 
renal tumor tissue (Figure 5b). The mass spectrometric probe was exploited in the MALDI-based imaging of cancer 
based on its cell surface carbohydrate.       
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Figure 5. (Left) Structure of compound 5. (Right) (a) MALDI-IMS and (b) immunostaining images of kidney tissue. Immunostaining 
and MALDI-IMS-boronolectin signal results overlap in the tumor region, not in the normal cell areas. (c) Boronolectin staining of 
a Sakura/UMFix alcohol fixed renal tumor tissue. Reproduced with permission from (Chem. Commun., 2011, 47, 10338). Copyright 
© 2012 Royal Society of Chemistry.    
In the recent work, Wang has reported that the over-expressed carbohydrate-based carcinoma biomarker, sialyl Lewis 
X was selectively labeled in the mouse xenograft tumor via a novel boronolectin-fluorophore 6.61 The fluorescent 
agent (Figure 6A) was injected via the tail vein into a mouse with xenograft (sc) tumor for fluorescent imaging. As 
can be seen from Figure 6B, after 24h washing period, compound 6 could be used to target a tumor. 
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Figure 6. Structure of compound 6 and its optical imaging of xenograft tumors by specific boronolectin-fluorophore 6, (A) mouse 
before imaging agent injection; (B): mouse 24 h after tail vein injection of the contrast agent showing almost exclusive delivery to 
the tumors site. Reproduced with permission from (Bioorg. Med. Chem. Lett. 2013, 23, 6307). Copyright © 2013 Elsevier Ltd. 
Above all, in Wang’s systems, compound 1 showed the most promising results for the binding with the 
important cancer-cell related biomarker sLex. The system has been further improved with the development 
of 5, 6 derived from compound 1, which have been successfully used for the imaging and labeling of 
carbohydrate-based biomarkers in cells and tissues.  
In the design of bisboronic acid system, peptides are versatile molecules with high biocompatibility and 
excellent water-solubility and can be used to target cancer cell detection and cancer diagnosis. Including 
binding with over-expressed bioactive sequences such as arginine-glycine-aspartic acid and its receptors 
(integrins of αvβ3 and αvβ5). For these reasons, peptide-based linkers have been widely employed in the 
construction of cancer specific receptor units. Therefore, functionalisation with boronic acid derivatives at 
different positions along the peptide back bone, has resulted in new sensing and labeling probes for the in 
situ recognition of cell-surface glycans for the targeted imaging of cancer cells.  
Lavigne and co-workers26 have prepared bisboronic acid-appended peptide library using a biased split-and-
pool combinatorial approach (Figure 7), the so-called peptide boronolectins (PBL) have been bound to beads 
and used for binding cancer related targets, such as oligosaccharide and glycoprotein. To investigate the 
ability of the peptides library to bind glycans, fluorescently labeled glycoproteins (FITC) including 
ovalbumin (Oval), bovine submaxillary mucin (BSM), and porcine stomach mucin (PSM) were assayed 
through color analysis output for each bead on an 8-bit scale and as revealed by the microscope images from 
Figure 8, the differential binding between different glycoproteins with peptide was observed which indicated 
the strong affinity between the bisboronic acid peptide receptors and the glycoproteins.   
 
 
Figure 7. Schematic representation of a phenylboronic acid substituted peptide (PBL, sequence chosen at random from ten amino 
acids) binding to a glycan or glycoprotein.  
A B 
Boronic acid 
 
Figure 8. Microscope images of individual beads responding to FITC-labeled glycoproteins (BSA 1% w/v; Oval, 100 μg mL-1; 
BSM, 500 μg mL-1; PSM, 500 μg mL-1) and the subsequent color (RGB) output analysis to the right of each image. The beads 
chosen represent selective (E1, G2), partially cross-reactive (H4), and completely cross-reactive (A6) library members. Reproduced 
with permission from (Chembiochem, 2007, 8, 2048-2051). Copyright © 2007 WILEY-VCH Verlag.  
Bisboronic acid-functionalised peptide-based fluorescent sensors (BPFSs) have been prepared by Zhang and co-
workers.62 They synthesised five BPFSs by incorporating anthracene-phenylboronic acid within different peptide 
chains (Figure 9). Those kind of sensors were then applied in situ recognition of cell-surface sLex and integrins for 
fluorescent imaging of target cells (Figure 9). In Figure 9 (B-E), fluorescence intensity of the cells increased as the 
incubation time between hepG2 cells and BPFS1 increasing by observing confocal laser scanning microscopy 
(CLSM) images. However, both the input of antibody and using BPFS1 analogue without boronic acid group into 
the cells keep the fluorescence intensity very low (Figure 9F1, 9G1). These structure-based screening processes 
demonstrated the specific recognition of cell-surface sLex using phenylboronic acid groups and those sensors were 
promising for the selective labeling of cell-surface glycans of human hepatic cancer cells.  
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Figure 9. (Left) Schematic presentation of BPFSs for in situ cancer cell recognition and imaging. (Right) (A): CLSM images63 of 
HepG2 cells incubated in free culture medium; (B–E): CLSM images of HepG2 cells incubated with BPFS1 (20 μM) for 1 min (B), 
3 min (C), 5 min (D) and 10 min (E); (F): CLSM images of HepG2 cells incubated with the antibody of CSLEX-1 for 15 min and 
then further incubated with BPFS1 (20 μM) for another 5 min; (G): CLSM images of HepG2 cells incubated with BPFS1 analogue 
(20 μM) without phenylboronic acid groups for 10 min; (H): CLSM images of HepG2 cells incubated with BPFS4 (20 μM) with a 
peptide sequence of FAGDF for 5 min. A1–H1: confocal fluorescence field images; A2–H2: bright field images. Reproduced with 
permission from (Sci. Rep. 2013, 3, 2679). Copyright © 2013 Nature Publishing Group.. 
Schepartz and co-workers64 evaluated a rhodamine-derived bisboronic acid RhoBo 7 (initially prepared as a 
monosaccharide sensor65) binding with peptides with 2-4 serine residues (each serine group presents a hydroxyl 
group for binding with the boronic acid receptor). Through testing different peptide sequences, it is observed that 
the RhoBo 7 formed the highest affinity complex with peptide containing the sequence Ser-Ser-Pro-Gly-Ser-Ser in 
buffer at 37 oC. Furthermore, they used Rhobo 7 to image tetraserine-containing proteins on saccharide-rich cell 
surface in the cytosol using epifluorescence (Epi) and total internal reflection fluorescence microscopy (TIRFM) 
clearly demonstrating that tetraserine could be selectively complexed and imaged even in the presence of saccharides. 
Figure 10 shows that only cells treated with RhoBo 7 show a significant signal (emission at 520 nm, no fluorescence 
signal without RhoBo) inside the cell with maximum intensity in the nucleus and outer plasma membrane (Figure 
10B). These phenomena suggested that RhoBo is a selective small-molecule tag for tetraserine-containing protein 
on and within living cells through high affinity complex formed with bisboronic acids.     
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Figure 10. (A) Experimental strategy to evaluate the extent of cell surface labelling by RhoBo. HeLa cells were transfected with 
pDisplay-mCherry (emission maximum 580 nm), incubated in the presence or absence of RhoBo (1 μM) (emission maximum 520 
nm), and (B) imaged using epifluorescent and TIRF microscopy. Reproduced with permission from (J. Am. Chem. Soc. 2009, 131, 
438). Copyright © 2009 American Chemical Society. 
Given the advantages of bisboronic acid-tagged peptides for the targeting and sensing of cell-surface biomarkers, it 
may be reasonable to assume the area will be further developed resulting in the design and development of systems 
for bio-imaging applications. Moreover, multiple boronic acids-tagged peptides would be further developed and 
applied in the sensing, targeting and labeling polysaccharides, or disease-related biomarkers.     
The next different example is using mono-boronic acid-based small-molecular fluorescent probe, Gois66 has 
developed fluorescent 2-acetylbenzeneboronic acids 8 and 9 that undergo B–N promoted conjugation with lysozyme 
and  N-(2-aminoethyl) folic acid (EDA-FA), resulting in conjugates that are selectively recognised and endocytosed 
by NCI-H460 cancer cells only when it over-expressed folic acid receptors (Figure 11). While in the control 
experiment lacking the boronic acid functionality hardly formed the expected constructs with the protein which 
highlight the contribution of boronic acid to imine stabilisation and internalisation of the conjugation.   
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Figure 11. Proposed structure of N–B based cancer cell targeting fluorescent conjugates 8 and 9. Optical imaging of xenograft 
tumor by specific boronolectin-fluorophore. (A): HEK and (B): NCI-H460 cells were incubated with compound 8; (C) NCI-H460 
and (D) NCI-H460 without and (E) with pre-treatment with EDA-FA were incubated with compounds 9; (F) NCI-H460 treated with 
no boron compound. Images show an overlay of the emission of compounds in the 460–580 nm regions upon excitation at 458 nm 
(green), and the emission of the membrane marker in the 650–700 nm regions upon excitation at 514 nm (red). Reproduced with 
permission from (Chem. Commun., 2014, 50, 5261). Copyright © 2014 Royal Society of Chemistry. 
Zhang and co-workers developed a peptide nanofibrous indicator (NFI) for naked eye-identification of cancer cells.67 
The nanofibrous indicator was prepared by mixing a borono-peptide (BP) with Alizarin Red S (compound 10). The 
nanofibrous self-assembly of BP/ARS produced β-sheets which can be dissociated by the addition of targets with 
higher binding affinities for the boronic acid than ARS (ie. monosaccharides and cell-surface carbohydrates 
overexpressed on certain cancer cells). The indicator displacement assay (IDA) system was evaluated both in vivo 
and in vitro allowing the naked-eye evaluation of cancer cells, using boronic acid binding with HepG2 cell-surface 
sLex (Figure 12). As can be seen from Figure 12A and 12C, the specific recognition between the boronic acid NFI 
A B 
8 
9 
and cell-surface sLex resulted in a weak fluorescence from ARS released from the BR/ARS complex. While HepG2 
and COS7 cells showed a strong red fluorescence (Figure 12B and 12D), indicating that the BP and ARS can be 
internalized and combine with each other to form a fluorescent BP/ARS complex.   
 
 
Figure 12. Confocal laser scanning images of HepG2/COS7 cells co-incubated with the NFI and with BP followed by the addition 
of ARS. A 1–3) HepG2 cells co-incubated with the NFI; B 1–3) HepG2 cells co-incubated with BP and then ARS added; C 1–3) COS7 
cells co-incubated with the NFI; D 1–3) COS7 cells co-incubated with BP and then ARS added. Reproduced with permission from 
(Small 2013, 9, 920). Copyright © 2013 WILEY-VCH Verlag. 
 
Polymer-tagged boronic acid probes for imaging application   
A significant enhancement in the binding of saccharide containing biomolecules, and hence the performance of a 
sensor system, can be achieved by incorporation of boronic acid units into a polymer matrix.6, 68, 69 Boronic acid-
containing polymers have been found out valuable in a variety of biomedical applications, including treatment of 
HIV,70, 71 obesity,72, 73 diabetes,6 and cancer.74, 75 Inclusion of the molecular sensor in the polymer can help in the 
development of superior analytical devices for carbohydrate imaging, since the polymer imparts many advantages 
such as improved robustness, sensitivity, handling, and biocompatibility. These properties are vital for the 
development of noninvasive biomolecular imaging tools. 76, 77 
In the design of a novel stimuli-responsive controlled-release system, Lin and co-workers78 visualised intracellular 
delivery of both insulin and cAMP (cyclic adenosine monophosphate) by using a 8-Fluo-cAMP-loaded BA-MSN 
particles (boronic acid-mesoporous silica nanoparticle) that can internalise within live RIN-5F cells (Scheme 1). The 
importance of this work is to overcome the difficulty of control of intracellular cAMP delivery by a drug carrier. By 
the introduction of saccharides (Figure 13b-c), green fluorescence in fluorescence confocal micrographs was clearly 
observed for both Fluo-cAMP-loaded BA-MSN particles and the free Fluo-cAMP molecules released from the MSN 
intracellularly by interaction of the boronic acid with glucose in live mammalian cells (Figure 13).  
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Scheme 1. Schematic representation of the glucose-responsive MSN-based delivery system for controlled release of bioactive 
gluconic acid-modified insulin (G-Ins) and cAMP. 
   
 
Figure 13. (a) Intracellular cAMP concentration of rat pancreatic RIN-5F cells treated with the cAMP-loaded BA-MSN (solid line) 
and free-solution cAMP (dashed line), measured after 6 h of introduction; (b) Fluorescence confocal micrograph of RIN-5F cells 
incubated with 20 μg mL−1 Fluo-cAMP-loaded BA-MSN (green) for 6 h.. Cell nuclei were stained with DAPI (blue). (c) 
Corresponding differential interference contrast (DIC) micrographs. (d) Fluorescence confocal and DIC merged image. 
Reproduced with permission from (J. Am. Chem. Soc. 2009, 131, 8398). Copyright © 2009 American Chemical Society. 
To make fluorescent glucose probes developed from QDs more practical for intracellular imaging, modified 
CdTe/ZnTe/ZnS core/shell/shell (CSS) QDs bearing phenylboronic acid (PBA) were prepared by Zhou et al. through 
attaching PBA-functionalised groups to QDs surface (Figure 14a).79 To monitor the glucose-mediated assembly of 
PBA-QDs, dynamic light scattering (DSL), TEM images were used to characterize the changes of QDs properties 
before and after the addition of glucose. The unique glucose-mediated assembly of PBA-QDs could be used to 
modulate the photoluminescence (PL) properties of the QDs and results in a selective ratiometric response towards 
glucose (Figure 14a). The ability of the PBA-QDs to enter cells and detect intracellular glucose levels in mouse 
melanoma B16F10 cells (grown in sugar-free Dulbecco modified Eagle medium) was then tested. When B16F10 
cells were treated with PBA-QDs, a cross-sectional Z scan confirmed the entry of the QDs into the cells (Figure 14b 
left). A continuous irradiation assay confirmed the photostability of the QDs in the cells. Subsequently the cells were 
fed with different amounts of glucose, and the emission maximum of PBA-QDs shifted from 590.2 nm to 596.7 nm 
and 609.8 nm corresponding to glucose at concentrations of about 4.0 and 15.9 mM, respectively (Figure 14b). Thus, 
the unique glucose-mediated assembly of PBA-modified QDs could be applied for a selective ratiometric response 
to glucose through modulating the PL properties of QDs in living cells.  
 
                
Figure 14. (a) Glucose-mediated assembly of PBA-modified CdTe/ZnTe/ZnS CSS QDs; (b) Scanning confocal fluorescence 
microscopy images (left), transmission microscopy images (center), and overlaid images (right) of mouse melanoma cells B16F10 
incubated with PBA-QDs (5.0 mg mL-1), with the additional feeding of glucose at concentrations. The local PL spectra were 
obtained from the regions within the yellow circles. Reproduced with permission from (Angew. Chem. Int. Ed. Engl., 2010, 122, 
6704). Copyright © 2010 WILEY-VCH Verlag. 
It is always challenging to design a fluorescence-based system for continuous glucose monitoring (CGM) 
in vivo even though it is so important to break through the difficulties. To overcome the barriers, an 
injectable hydrogel fashioned into microbeads, which incorporates an established glucose selective 
fluorescent sensor (GF-hydrogel) was reported for the first time by Takeuchi and co-workers (Figure 15 
Left). The glucose-responsive bead (GF) system demonstrated highly-sensitive, bio-stable, long-lasting, and 
injectable properties for in vivo continuous glucose detection (Figure 15 Right). Significantly, the 
fluorescence intensity of the injected GF-beads was transdermally detectable and visible through the ear 
skin of mice without any abnormalities for over 30 days (Figure 15A-B). They also experimentally verified 
the correlation between the fluorescence intensity of the implanted GF-beads and the in vivo blood glucose 
concentrations (370 mg.dL-1 – 130 mg.dL-1, modulated by insulin) by nine intravenous glucose infusions 
and found out that fluorescence intensity of the microbeads could be used to accurately monitor the blood 
glucose concentrations (Figure 15C-G).        
  
                        
Figure 15. (Left) Typical structure of GF-polyacrylamide hydrogels; (Right) In vivo CGM in a mouse using injected GF-beads. (A, 
B) glucose responsive fluorescence beads under the dermis of a mouse ear. (C) Enlarged view of the implantation site in the mouse 
ear. (D, E) Fluorescent images for glucose concentration within the euglycemic and hyperglycemic ranges, respectively. (F, G) 
Pseudocolored images of D and E. Reproduced with permission from (Proc. Natl. Acad. Sci. U.S.A 2010, 107, 17894) Copyright 
© by the National Academy of Sciences. 
In order to address two limitations: i) that continuous glucose monitoring may not be required over the 
(a) (b) 
whole lifetime of the subject and ii) that the microbeads slowly disperse, they have moved to a more robust 
and easily removable fiber sensor system.80 The fiber material consists of polyethylene glycol (PEG)-
bonded polyacrylamine (PAM) hydrogel and incorporates the same sensor unit .81 In their smart structure 
design, polyethylene glycol (PEG)-bonded polyacrylamide (PAM) hydrogel fibers (better performance than PAM 
hydrogel fibers) were employed since they can reduce inflammation and continuously respond to blood glucose 
changes for up to 140 days. The fiber system can be used for long-term in vivo glucose monitoring, fibers still 
showed a very strong fluorescence signal through ear skin even one month after implantation (Figure 16). 
These fibers can also be implanted and removed quickly and simply (Figure 17), which has the additional 
advantage that maybe unknown long-term side effects are not given the chance to manifest. 
     
 
 
Figure 16. Inflammation induced by the implanted fibers and transdermal transmission over a long period. The 
comparison of fluorescence intensity of the PAM hydrogel fibers with and without PEG through the ear skin for one month. 
Reproduced with permission from (Proc. Natl. Acad. Sci. U.S.A 2011, 108, 13399) Copyright © by the National Academy of 
Sciences.    
 
 
Figure 17. The implanted fiber can be easily removed from the implantation site after use. (A) Fiber implanted into the mouse ear. 
(B) The implanted fiber was easily removed from the ear. (C) Fluorescence image of the mouse ear before removing. (D) Fluorescent 
image after fiber removal. Reproduced with permission from (Proc. Natl. Acad. Sci. U.S.A 2011, 108, 13399) Copyright © by the 
National Academy of Sciences.  
In addition, Elsen has demonstrated that glycated proteins can be visualized and identified in a variety of complex 
biological samples, including human serum, Manduca sexta hemolymph and mouse brain cortex homogenates, using 
fluorescent boronic acids in Flu-PAGE and Flu-BLOT.  
Benzoxaborole-based probes for saccharide imaging applications   
Dennis Hall pioneered the use of the benzoxaborole 11 (ortho-hydroxymethyl phenylboronic acid) receptor which 
has been shown to be a superior receptor unit to the well-established dialkylamino boronic acids (Wulff type, 
compounds 1 - 9) analogues.83 The benzoxaborole 11 unit binds strongly with 4,6-diols and as such can be used to 
complex strongly with cell-surface glycoconjugates.84  
PEG-bonded PAM PAM 
Day 0 
Day 31 
(b) 
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Scheme 2. Reversible covalent bonding between benzoborole and glycopyranoside. 
Inefficient cellular delivery limits the application of macromolecular drugs.85, 86 Therefore, through the targeting of 
therapeutic agents to the glycocalyx, it is anticipated that this would enhance the cellular delivery of the drug. In 
order to evaluate this concept, Raines has conjugated benzoxaborole moieties with bovine pancreatic ribonuclease 
(RNase A) and used the enhanced affinity towards: D-fructose, D-glucose and N-acetylneuraminic (Neu5Ac) to aid 
intracellular targeting of the conjugate.87 In the design, 5-amino-2-hydroxymethylphenylboronic acid was linked via 
an amide bond to the protein carboxyl groups using a carbodiimide coupling agent (Figure 18a). A fluorophore-
labeled protein and flow cytometry was used to quantify cellular internalisation. Chinese hamster ovary cells (Lec-
2) were employed since they have lower levels of sialic acid in their glycocalyx than their progenitor line (Pro-5). 
This experiment was designed to determine whether the conjugated benzoxaborole would elicit selectivity for cells 
with higher quantities of cell-surface sialic acid since sialic acid is of high abundance in the glycocalyx. It is found 
out that boronation of RNase A increased its cellular uptake by 4 to 5-fold (Figure 18b). Thus, it was shown that the 
boronated protein has enhanced affinity for in vitro oligosaccharides and also facilitates cellular uptake of the protein 
and enhances protein delivery to the cytosol. It was concluded that such benzoxaborole have many attractive 
attributes and could be used as ideal mediators in drug delivery. 
 
 
 
                      
Figure 18. (a) Boronation of RNase A and its proposed mechanism for expediting cellular delivery. The location of each carboxyl 
group of RNase A is depicted in the ribbon diagram. (b) Internalization of unmodified and boronated RNase A into Pro-5 and Lec-
2 cells in the absence or presence of fructose. Flow cytometry data were normalized to the internalization of unmodified RNase A 
into Pro-5 cells. Error bars represent SDs. Inset: Confocal microscopy image of live Pro-5 cells incubated for 4 h with boronated 
RNase A that had been labeled covalently with a green fluorophore. Nuclei were stained blue with Hoechst 33322. Reproduced 
with permission from (J. Am. Chem. Soc. 2012, 134, 3631). Copyright © 2012 American Chemical Society. 
    Kim developed a benzoxaborole-containing styrenic monomer which can be polymerised by the reversible 
addition−fragmentation and chain transfer method (Scheme 3).88 Fluorescein isothiocyanate (FITC)-labeled human 
insulin (F-insulin) was encapsulated within polymersomes, in order to demonstration their use as sugar-responsive 
containers. The strong green fluorescence of the polymersomes was observed using laser confocal fluorescence 
microscopy (LCFM, Figure 19). Subsequently, under physiologically relevant pH conditions, the FITC labelled 
insulin was released from the polymersomes in response to added monosaccharides that bind strongly with the 
(a) 
benzoxaborole moieties. 
 
Scheme 3. Self-assembly of PEG-b-PBOx and its disassembly in the presence of monosaccharides. 
 
Figure 19. LCFM images of polymersomes of PEG-b-PBOx encapsulating FITC-labelled human insulin: (A) dark-field, (B) 
bright-field; (C) merged. Scale Bar: 5 μm. Reproduced with permission from (J. Am. Chem. Soc. 2012, 134, 4030). Copyright 
© 2012 American Chemical Society. 
Conclusions  
Cellular imaging using fluorescent reporter systems for tagging cellular and subcellular processes in vivo 
have been extensively developed over the past decade but many important challenges remain, such as 
chemoselectivity and bioorthognity, continuous in vivo monitoring. It is clear that if more research can be 
encouraged in this area then substantial developments will be possible and these will impact the way we 
currently do biological research, drug discovery, and clinical practice. Especially, given the rapid 
development of super-resolution fluorescence microscopy (2014 Nobel Prize in chemistry), which will 
bolster the development of fluorescent molecular imaging for diagnostics and also the monitoring disease 
progression and recovery at the molecular level.89 Carbohydrates are particularly important targets given their 
pivotal role in numerous important biological events, including the development and progression of many diseases. 
Boronic acids (BA) are a class of receptors very well suited to the binding of carbohydrates, since even the simplest 
BA receptors have high affinity for carbohydrates under biologically relevant conditions (in water). Putting things 
into perspective if boronic acid based imaging agents could aid in the development of early stage diagnostics or aid 
the development of treatment for just one disease such Alzheimer’s disease (AD). Then, the overall economic impact 
would be immense, since the current economic burden of dementia per year on the UK is £26.3 billion.90 Obviously, 
the answer to this problem is not going to be easy but given the rapid growth of interest in selective “fluorescence 
imaging” and potential of boronic acid based receptors discussed in this review we hope that solutions to these 
problems will be provided in the relatively near future. 
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